Modulation of the Receptor Tyrosine Kinase TIE2/Tek Pathway by NRF2 Activation in Neurovascular Endothelial Cells

Eduardo Cazalla1,2,3,4, Ángel Juan García-Yagüe1,2,3,4, Marta Pajares1,2,3,4

  • 1Department of Biochemistry, School of Medicine, Autonomous University of Madrid (UAM), 28049 Madrid, Spain.

Insights

The transcription factor NRF2 impacts angiogenesis by downregulating the TIE2/Tek receptor in mouse neuroendothelial cells. This regulation occurs independently of BACH1 and direct transcriptional control, suggesting novel NRF2-mediated mechanisms.

Area of Science:

  • Endothelial biology
  • Molecular mechanisms of angiogenesis
  • Cellular homeostasis

Background:

  • The transcription factor NRF2 regulates cellular responses to stress and maintains homeostasis.
  • NRF2's specific role in angiogenesis, the formation of new blood vessels, is not well-defined.
  • Endothelial cells form the inner lining of blood vessels and are crucial for vascular integrity and development.

Purpose of the Study:

  • To investigate the role of the transcription factor NRF2 in regulating genes involved in endothelial cell biology.
  • To determine the effect of NRF2 modulation on the expression of the TIE2/Tek receptor, a key regulator of angiogenesis.
  • To elucidate the molecular mechanisms by which NRF2 influences TIE2/Tek expression.

Main Methods:

  • Genetic and pharmacological manipulation of NRF2 in mouse neuroendothelial cells.
  • Analysis of gene expression changes, including adherens and tight junction genes.
  • Investigation of TIE2/Tek regulation using hemin treatment, BACH1 knockdown, mRNA stability assays, and ChIP analysis.

Main Results:

  • NRF2 activation led to the downregulation of the TIE2/Tek receptor in mouse neuroendothelial cells.
  • Changes in the expression of genes associated with adherens and tight junctions were observed.
  • TIE2/Tek repression by NRF2 was found to be independent of the NRF2 repressor BACH1.
  • Post-transcriptional or direct transcriptional repression by NRF2 was ruled out through mRNA stability and ChIP analyses.

Conclusions:

  • NRF2 activation influences angiogenesis by downregulating the TIE2/Tek receptor.
  • The mechanism of NRF2-mediated TIE2/Tek regulation is not direct transcriptional or post-transcriptional.
  • These findings suggest an alternative NRF2-dependent pathway affecting TIE2/Tek levels, impacting angiogenic processes.

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
18.4K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
86.5K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.1K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
518
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.4K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
3.0K